<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Aripiprazole Metabolic Pathway" Author="Egon Willighagen" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">The CYP P450 metabolism of aripiprazole has been studied and described in several papers (like the one in the bibliography), except for the original primary literature describing the experiments and the exact metabolite structures. The two CYPs are said to be involved in N-dealkylation and dehydrogenation. </Comment>
  <BiopaxRef>bcf</BiopaxRef>
  <BiopaxRef>f29</BiopaxRef>
  <BiopaxRef>e76</BiopaxRef>
  <BiopaxRef>ba3</BiopaxRef>
  <BiopaxRef>f97</BiopaxRef>
  <Graphics BoardWidth="512.0" BoardHeight="233.0"/>
  <DataNode TextLabel="aripiprazole" GraphId="cf694" Type="Metabolite">
    <Graphics CenterX="211.0" CenterY="86.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff"/>
    <Xref Database="HMDB" ID="HMDB05042"/>
  </DataNode>
  <DataNode TextLabel="dehydroaripiprazole" GraphId="d02eb" Type="Metabolite">
    <Comment>Also known as OPC14857.</Comment>
    <BiopaxRef>e76</BiopaxRef>
    <Graphics CenterX="427.0" CenterY="86.0" Width="110.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff"/>
    <Xref Database="PubChem-compound" ID="10114519"/>
  </DataNode>
  <DataNode TextLabel="CYP2D6" GraphId="c1ed5" Type="GeneProduct">
    <Graphics CenterX="311.0" CenterY="38.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000100197"/>
  </DataNode>
  <DataNode TextLabel="Product" GraphId="dd805" Type="Metabolite">
    <Graphics CenterX="211.0" CenterY="193.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff"/>
    <Xref Database="ChEBI" ID="CHEBI:25212"/>
  </DataNode>
  <DataNode TextLabel="CYP3A43" GraphId="ef6ee" Type="GeneProduct">
    <Graphics CenterX="121.0" CenterY="139.0" Width="80.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000021461"/>
  </DataNode>
  <Interaction GraphId="idf965780e">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="251.0" Y="86.0" GraphRef="cf694" RelX="1.0" RelY="0.0"/>
      <Point X="372.0" Y="86.0" GraphRef="d02eb" RelX="-1.0" RelY="0.0" ArrowHead="mim-conversion"/>
      <Anchor Position="0.5" Shape="None" GraphId="e20cc"/>
    </Graphics>
    <Xref Database="XMetDB" ID="XMETDB172"/>
  </Interaction>
  <Interaction GraphId="id403afc34">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="311.0" Y="48.0" GraphRef="c1ed5" RelX="0.0" RelY="1.0"/>
      <Point X="311.5" Y="86.0" GraphRef="e20cc" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id7653b8d8">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="211.0" Y="96.0" GraphRef="cf694" RelX="0.0" RelY="1.0"/>
      <Point X="211.0" Y="183.0" GraphRef="dd805" RelX="0.0" RelY="-1.0" ArrowHead="Arrow"/>
      <Anchor Position="0.5" Shape="None" GraphId="baa08"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id6b0af018">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="161.0" Y="139.0" GraphRef="ef6ee" RelX="1.0" RelY="0.0"/>
      <Point X="211.0" Y="139.5" GraphRef="baa08" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <InfoBox CenterX="0.0" CenterY="0.0"/>
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ba3">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">17164689</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pharmacokinetic variability of aripiprazole and the active metabolite dehydroaripiprazole in psychiatric patients.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ther Drug Monit</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2006</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Molden E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lunde H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lunder N</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Refsum H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f29">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">15257633</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Drugs</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2004</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Swainston Harrison T</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Perry CM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f97">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">17214606</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Metabolic drug interactions with newer antipsychotics: a comparative review.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Basic Clin Pharmacol Toxicol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2007</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Spina E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">de Leon J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e76">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">15770075</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Influence of itraconazole co-administration and CYP2D6 genotype on the pharmacokinetics of the new antipsychotic ARIPIPRAZOLE.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Drug Metab Pharmacokinet</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2005</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kubo M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Koue T</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inaba A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Takeda H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Maune H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fukuda T</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Azuma J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">phase I biotransformation pathway via cytochrome P450</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000375</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bcf">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">14998222</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Aripiprazole, a novel atypical antipsychotic drug.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pharmacotherapy</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2004</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Argo TR</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Carnahan RM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Perry PJ</bp:AUTHORS>
    </bp:PublicationXref>
  <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#"><bp:TERM>xenobiotic metabolic pathway</bp:TERM><bp:ID>PW:0001229</bp:ID><bp:Ontology>Pathway Ontology</bp:Ontology></bp:openControlledVocabulary></Biopax>
</Pathway>